Literature DB >> 18936525

Relationship between dyskerin expression and telomerase activity in human breast cancer.

Lorenzo Montanaro1, Maria Calienni, Claudio Ceccarelli, Donatella Santini, Mario Taffurelli, Stefano Pileri, Davide Treré, Massimo Derenzini.   

Abstract

The nucleolar protein dyskerin is involved in the modification of specific uridine residues to pseudouridine on ribosomal and small nuclear RNAs and in the stabilization of the telomerase RNA component (TERC). In this study we investigated for the first time the relationship between dyskerin expression and telomerase activity in a series of 61 primary breast carcinomas. We found that when dyskerin mRNA values were very low the telomerase activity was markedly reduced, independently of the expression of other important components of the telomerase complex such as telomerase reverse transcriptase (TERT). In vitro experiments showed that reduction of dyskerin expression affect telomerase activity through the reduction of TERC. Only when TERC levels were strongly reduced telomerase activity was hindered. Retroviral mediated over-expression of TERC abolished the telomerase impairment due to dyskerin knock down. In conclusion, our results indicated that, beside its effect on ribosome biogenesis, the levels of dyskerin in cancer cells modulate telomerase activity through the regulation of TERC levels, independently of TERT expression. This should be taken into consideration when utilizing TERT expression as a surrogate indicator of telomerase activity in tumour pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936525      PMCID: PMC4618991          DOI: 10.3233/clo-2008-0436

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  21 in total

1.  Telomere length and cancer mortality in American Indians: the Strong Heart Study.

Authors:  Pooja Subedi; Stefano Nembrini; Qiang An; Yun Zhu; Hao Peng; Fawn Yeh; Shelley A Cole; Dorothy A Rhoades; Elisa T Lee; Jinying Zhao
Journal:  Geroscience       Date:  2019-06-22       Impact factor: 7.713

Review 2.  TERT Promoter Mutations in Thyroid Cancer.

Authors:  Ali S Alzahrani; Rawan Alsaadi; Avaniyapuram Kannan Murugan; Bakr Bin Sadiq
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

3.  Correlation of dyskerin expression with active proliferation independent of telomerase.

Authors:  Faizan Alawi; Ping Lin; Barry Ziober; Reena Patel
Journal:  Head Neck       Date:  2010-12-08       Impact factor: 3.147

Review 4.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

Review 5.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

6.  Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.

Authors:  Erin M Parry; Jonathan K Alder; Stella S Lee; John A Phillips; James E Loyd; Priya Duggal; Mary Armanios
Journal:  J Med Genet       Date:  2011-03-17       Impact factor: 6.318

7.  A novel lncRNA derived from an ultraconserved region: lnc-uc.147, a potential biomarker in luminal A breast cancer.

Authors:  Erika Pereira Zambalde; Recep Bayraktar; Tayana Schultz Jucoski; Cristina Ivan; Ana Carolina Rodrigues; Carolina Mathias; Erik Knutsen; Rubens Silveira de Lima; Daniela Fiori Gradia; Enilze Maria de Souza Fonseca Ribeiro; Samir Hannash; George Adrian Calin; Jaqueline Carvalhode Oliveira
Journal:  RNA Biol       Date:  2021-08-13       Impact factor: 4.766

8.  Integrated In Silico Analyses Identify PUF60 and SF3A3 as New Spliceosome-Related Breast Cancer RNA-Binding Proteins.

Authors:  Jennyfer M García-Cárdenas; Isaac Armendáriz-Castillo; Andy Pérez-Villa; Alberto Indacochea; Andrea Jácome-Alvarado; Andrés López-Cortés; Santiago Guerrero
Journal:  Biology (Basel)       Date:  2022-03-22

9.  DKC1 overexpression associated with prostate cancer progression.

Authors:  P Sieron; C Hader; J Hatina; R Engers; A Wlazlinski; M Müller; W A Schulz
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

10.  Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.

Authors:  Bei Liu; Jinglei Zhang; Chen Huang; Hui Liu
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.